Wu, F., et al. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269.
Article CAS PubMed PubMed Central Google Scholar
Hosseinzadeh, P. (2022). Social consequences of the COVID-19 pandemic. A systematic review. Invest Educ Enferm, 40(1).
Lenz, C. (2023). Long-term effects of COVID-19: A review of current perspectives and mechanistic insights. Critical Reviews in Microbiology, : p. 1–14.
van Dam, P., et al. (2021). Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests. European Journal of Cancer, 148, 328–339.
Article PubMed PubMed Central Google Scholar
Peeters, M., et al. (2021). Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment. ESMO Open, 6(5), 100274.
Article CAS PubMed PubMed Central Google Scholar
Dubey, S., et al. (2020). Psychosocial impact of COVID-19. Diabetes Metab Syndr, 14(5), 779–788.
Article PubMed PubMed Central Google Scholar
Verma, R., Kilgour, H. M., & Haase, K. R. (2022). The Psychosocial Impact of COVID-19 on older adults with Cancer: A Rapid Review. Current Oncology (Toronto, Ont.), 29(2), 589–601.
Pedrosa, A. L., et al. (2020). Emotional, behavioral, and psychological impact of the COVID-19 pandemic. Frontiers in Psychology, 11, 566212.
Article PubMed PubMed Central Google Scholar
Poudel, A. N., et al. (2021). Impact of Covid-19 on health-related quality of life of patients: A structured review. PLoS One, 16(10), e0259164.
Article CAS PubMed PubMed Central Google Scholar
Said, C. M., Batchelor, F., & Duque, G. (2022). The impact of the COVID-19 pandemic on physical activity, function, and Quality of Life. Clinics in Geriatric Medicine, 38(3), 519–531.
Article PubMed PubMed Central Google Scholar
Baffert, K. A., et al. (2021). Quality of life of patients with Cancer during the COVID-19 pandemic. Vivo, 35(1), 663–670.
Wang, Y., et al. (2020). Anxiety and depression among tibetan inpatients with cancer: A multicenter investigation. Ann Palliat Med, 9(6), 3776–3784.
Dagher, H. (2023). Long COVID in cancer patients: Preponderance of symptoms in majority of patients over long time period. Elife, 12.
Fankuchen, O., et al. (2023). Long COVID in Cancer: A matched cohort study of 1-year Mortality and Long COVID Prevalence among patients with Cancer who survived an initial severe SARS-CoV-2 infection. American Journal of Clinical Oncology, 46(7), 300–305.
Article CAS PubMed PubMed Central Google Scholar
Monroy-Iglesias, M. J., et al. (2022). Long-term effects of COVID-19 on cancer patients: The experience from Guy’s Cancer Centre. Future Oncology, 18(32), 3585–3594.
Article CAS PubMed Google Scholar
Kamal, M., et al. (2021). Assessment and characterisation of post-COVID-19 manifestations. International Journal of Clinical Practice, 75(3), e13746.
Article CAS PubMed Google Scholar
Hastie, C. E., et al. (2023). True prevalence of long-COVID in a nationwide, population cohort study. Nature Communications, 14(1), 7892.
Article CAS PubMed PubMed Central Google Scholar
Saini, G., & Aneja, R. (2021). Cancer as a prospective sequela of long COVID-19. Bioessays, 43(6), e2000331.
Lai, C. C., et al. (2023). Long COVID: An inevitable sequela of SARS-CoV-2 infection. Journal of Microbiology, Immunology, and Infection, 56(1), 1–9.
Healey, Q., et al. (2022). Symptoms and signs of long COVID: A rapid review and meta-analysis. J Glob Health, 12, 05014.
Article PubMed PubMed Central Google Scholar
Davis, H. E., et al. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133–146.
Article CAS PubMed PubMed Central Google Scholar
Marshall, M. (2020). The lasting misery of coronavirus long-haulers. Nature, 585(7825), 339–341.
Article CAS PubMed Google Scholar
Davis, H. E., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38, 101019.
Article PubMed PubMed Central Google Scholar
Debie, Y., et al. (2023). Humoral and Cellular Immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with Cancer. Clinical Cancer Research, 29(3), 635–646.
Article CAS PubMed Google Scholar
Debie, Y., et al. (2023). Boosting capacity of a fourth dose BNT162b2 in cancer patients. European Journal of Cancer, 179, 121–123.
Article CAS PubMed Google Scholar
Debie, Y. (2021). Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in Cancer patients. European Journal of Cancer.
van Dam, P. A. (2022). Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients. ESMO Open, : p. 100414.
Fayers, P., et al. (2002). Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. European Journal of Cancer, 38(Suppl 4), S125–S133.
Broadbent, D. E., et al. (1982). The cognitive failures questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21(1), 1–16.
Article CAS PubMed Google Scholar
Caunt, J. Derbyshire Post Covid Syndrome Questionnaire. Derbyshire Post Covid Syndrome Questionnaire 2020 [cited 2023 24 April].
Burns, G. Newcastle post-COVID syndrome Follow Up Screening Questionnaire. Newcastle post-COVID syndrome Follow Up Screening Questionnaire 2020 [cited 2023 24 April].
Turunen, H., Perälä, M. L., & Meriläinen, P. (1994). [Modification of Colaizzi’s phenomenological method; a study concerning quality care]. Hoitotiede, 6(1), 8–15.
Pinato, D. J., et al. (2021). Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: Evidence from the OnCovid retrospective, multicentre registry study. The Lancet Oncology, 22(12), 1669–1680.
Article CAS PubMed PubMed Central Google Scholar
Logue, J. K., et al. (2021). Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open, 4(2), e210830.
Article PubMed PubMed Central Google Scholar
Subramanian, A., et al. (2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine, 28(8), 1706–1714.
Article CAS PubMed PubMed Central Google Scholar
Huang, C., et al. (2023). 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet, 401(10393), e21–e33.
Article PubMed PubMed Central Google Scholar
Magasi, S. (2022). Cancer Survivors’ Disability Experiences and Identities: A Qualitative Exploration to Advance Cancer Equity. International Journal of Environmental Research and Public Health, 19(5).
Crook, H., et al. (2021). Long covid-mechanisms, risk factors, and management. Bmj, 374, n1648.
Comments (0)